| Autor: |
Im, Su, Cho, Sean, Hwang, Jeong, Jin Lee, Seung |
| Zdroj: |
Archives of Pharmacal Research; Jan2003, Vol. 26 Issue 1, p76-82, 7p |
| Abstrakt: |
Drug releasing porous potyts-caprolactone) (PCl)-chitosan matrices were fabricated for bone regenerative therapy. Porous matrices made of biodegradable polymers have been playing a crucial role as bone substitutes and as tissue-engineered scaffolds in bone regenerative therapy. The matrices provided mechanical support for the developing tissue and enhanced tissue formation by releasing active agent in controlled manner. Chitosan was employed to enhance hydrophilicity and biocompatibility of the PCl matrices. PDGF-88 was incorporated into PClchitosan matrices to induce enhanced bone regeneration efficacy. PCL-chitosan matrices retained a porous structure with a 100-200 urn pore diameter that was suitable for cellular migration and osteoid ingrowth. NaHC03 as a porogen was incorporated 5% ratio to polymer weight to form highly porous scaffolds. PDGF-88 was released from PCL-chitosan matrices maintaining therapeutic concentration for 4 week. High osteoblasts attachment level and proliferation was observed from PCL-chitosan matrices. Scanning electron microscopic examination indicated that cultured osteoblasts showed round form and spread pseudopods after 1 day and showed broad cytoplasmic extension after 14 days. PCL-chitosan matrices promoted bone regeneration and PDGF-8B loaded matrices obtained enhanced bone formation in rat calvarial defect. These results suggested that the PDGF-BB releasing PCL-chitosan porous matrices may be potentially used as tissue engineering scaffolds or bone substitutes with high bone regenerative efficacy. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink